September 13, 2024

Supplementary Figure 2 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure 2. PMP-PDX models resemble histological features of the original patient sample with massive mucinous secretion and preserve invasiveness.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Martínez‐Quintanilla et al. (2024) studied this question.

synapsesocial.com/papers/68e58a5ab6db64358752632e https://doi.org/10.1158/1078-0432.27013772

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure 2. PMP-PDX models resemble histological features of the original patient sample with massive mucinous secretion and preserve invasiveness.

Supplementary Figure 2 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei

Abstract

Discussion

Cite This Study

Supplementary Figure 2 from Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei

Abstract

Discussion

Cite This Study

Also Consider

Also Consider